Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Quantum BioPharma Clarifies It Has Not Changed Its Name
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces its response to information about certain stock trading platforms as well as misinformation being circulated on certain social media channels. Certain stock trading platforms mistakenly have the Quantum BioPharma name changed to Unbuzzd Wellness Inc. (formerly, Celly Nutrition Corp.) after the news release was issued on May 29, 2025. Quantum BioPharma has not changed its name.» Mehr auf globenewswire.com
iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients
Study Aims to Expedite Potentially Transformative Therapies By Assessing Safety and Efficacy of FSD202 Study Aims to Expedite Potentially Transformative Therapies By Assessing Safety and Efficacy of FSD202» Mehr auf globenewswire.com
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari
Dr. Raza Bokhari, Company's Former CEO, Paid $2.35 Million USD in Non-Dilutive Cash to Cover Legal and Other Costs Determined in the Arbitral Award Over the Past 4 Years Dr. Raza Bokhari, Company's Former CEO, Paid $2.35 Million USD in Non-Dilutive Cash to Cover Legal and Other Costs Determined in the Arbitral Award Over the Past 4 Years» Mehr auf globenewswire.com
Unternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 0,00 | - |
Bruttoeinkommen | −119,52k | - |
Nettoeinkommen | −7,90 Mio | 348,17% |
EBITDA | −7,61 Mio | 321,25% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 39,53 Mio€ |
Anzahl Aktien | 2,91 Mio |
52 Wochen-Hoch/Tief | 20,93€ - 2,37€ |
Dividenden | Nein |
Beta | 1,47 |
KGV (PE Ratio) | −0,84 |
KGWV (PEG Ratio) | 0,03 |
KBV (PB Ratio) | 3,06 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
Name | Quantum BioPharma Aktie |
CEO | Zeeshan Saeed |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
München | 0K91.MU |
Düsseldorf | 0K91.DU |
Frankfurt | 0K91.F |
NASDAQ | QNTM |
Assets entdecken
Shareholder von Quantum BioPharma Aktie investieren auch in folgende Assets